Skip to content

Caffeinated Gum Use and Volleyball Performance

Acute Effects of Caffeinated Gum Use on Volleyball Performance: A Randomized, Placebo-Controlled Crossover Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07597265
Enrollment
11
Registered
2026-05-19
Start date
2025-08-05
Completion date
2026-04-23
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volleyball Players, Performance

Keywords

Caffeine, Caffeinated gum, Volleyball, Athletic performance, Vertical jump

Brief summary

This study examined the acute effects of caffeinated chewing gum on volleyball performance in trained female volleyball players. Caffeine is commonly used by athletes to improve performance, but less is known about whether caffeinated gum is useful during volleyball-specific activity. Participants completed three testing sessions in a randomized crossover design. In one session, they chewed placebo gum. In another session, they chewed caffeinated gum containing a single 300 mg dose of caffeine. In the third session, they received the same total amount of caffeine as three separate 100 mg doses given at 30-minute intervals. The study assessed volleyball-specific skill performance, including attack, block, and defense efficiency, during a volleyball-specific skill game. Vertical jump height, heart rate, perceived exertion, side effects, and condition guessing were also recorded.

Detailed description

This randomized, placebo-controlled, crossover study investigated whether the pattern of caffeinated gum administration affects volleyball-specific performance in trained female volleyball players. Participants completed one familiarization session and three experimental sessions separated by one week. The experimental conditions were placebo gum, single-dose caffeinated gum, and partial-dose caffeinated gum. In the single-dose condition, participants chewed three pieces of caffeinated gum containing a total of 300 mg caffeine for 5 minutes. In the partial-dose condition, participants chewed one piece of caffeinated gum containing 100 mg caffeine at three different time points, with 30-minute intervals between doses. In the placebo condition, participants chewed caffeine-free gum for 5 minutes. Each testing session included volleyball-specific activities and a 30-minute volleyball-specific skill game. Attack, block, and defense efficiency were assessed using video recordings and Data Volley software. Vertical jump height was measured before and after the volleyball-specific activity. Heart rate was recorded during the session, and rating of perceived exertion was assessed before and after the session. Participants were also asked to report side effects and to guess which condition they had received after each session.

Interventions

DIETARY_SUPPLEMENTSingle-dose caffeinated gum

Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine. The gum was chewed for 5 minutes and then discarded.

DIETARY_SUPPLEMENTPartial-dose caffeinated gum

Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece. One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.

DIETARY_SUPPLEMENTPlacebo gum

Participants chewed caffeine-free placebo gum for 5 minutes. The placebo gum was selected to be similar in shape and color to the caffeinated gum.

Sponsors

Ege University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Female volleyball players aged 18 to 35 years. * Apparently healthy. * Daily caffeine intake ≤300 mg. * Minimum of 5 years of regular volleyball training experience. * Training for at least 120 minutes at least 3 days per week. * Competing in national or international volleyball matches. * Provided written informed consent before participation.

Exclusion criteria

* Serious injury or trauma within the past 6 months that could affect volleyball performance. * Illness or inability to continue the study protocol during the research period. * Development of side effects during caffeinated gum administration that prevented continuation. * Regular alcohol or drug use that could affect the study outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Attack efficiencyDuring the 30-minute volleyball-specific skill game in each experimental trialAttack efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software. Values were expressed as percentages.
Block efficiencyDuring the 30-minute volleyball-specific skill game in each experimental trialBlock efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software. Values were expressed as percentages.
Defense efficiencyDuring the 30-minute volleyball-specific skill game in each experimental trialDefense efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software. Values were expressed as percentages.

Secondary

MeasureTime frameDescription
Change in vertical jump heightFrom immediately before to immediately after each experimental trialVertical jump height was measured before and after each experimental testing session using a photoelectric cell system. Values were expressed in centimeters.
Heart rateContinuously during each experimental trialHeart rate was recorded during each experimental testing session using a telemetric heart rate monitoring system. Values were expressed as beats per minute.
Change in rating of perceived exertionFrom immediately before to immediately after each experimental trialRating of perceived exertion was assessed before and after each experimental testing session using a 0-10 Borg scale.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026